AbbVie Inc. (ABBV) Stock Forecast 2026: P10, P50 & P90 — Probabli.AI
Timestamped ABBV stock forecast with 1-year P10, P50, and P90 price estimates, scenario probabilities, definitions, sources, and limitations.
Direct answer: AbbVie Inc. commands a strong position in the pharmaceutical sector, underpinned by its innovative drug portfolio and robust cash flow generation. Despite challenges such as competition from biosimilars and high payout ratios, its strategic initiatives, including acquisitions and pipeline expansion, paint a favorable outlook. Investor confidence is buoyed by a positive analyst consensus and a sustainable dividend yield. The saved 1-year distribution is P10 $175, P50 $210, and P90 $260.
Last analyzed · Model: gpt-4o
AbbVie Inc. Forecast data
| Estimate | 1-year price | Meaning |
|---|
| P10 | $175 | Pessimistic plausible scenario |
| P50 | $210 | Median scenario |
| P90 | $260 | Optimistic plausible scenario |
What the numbers mean
P10, P50, and P90 are model-generated scenario estimates: roughly a pessimistic plausible outcome, a median outcome, and an optimistic plausible outcome. They are not calibrated confidence intervals.
Supporting analysis
AbbVie has strong fundamentals supported by a robust product line, attractive dividend yield, and consensus buy recommendations from analysts. However, potential competitive pressures, including biosimilars and patent expirations, pose short-term risks.
Sources and limitations
Market and company inputs are primarily sourced through Yahoo Finance and public financial-data interfaces. This page reports a saved AI-generated scenario analysis as of the timestamp above; it is not live data, audited probability, financial advice, or a guaranteed return.
Frequently asked questions
When was this ABBV analysis generated?
April 29, 2026.
Is this a guaranteed ABBV prediction?
No. It is a model-generated scenario assessment with material uncertainty.
View the full ABBV stock analysis · ABBV sentiment · Methodology · Accuracy & validation
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.